サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541515

口腔乾燥症（ドライマウス）治療薬市場レポート：タイプ別、薬剤タイプ別、流通チャネル別、地域別2024-2032

Xerostomia Therapeutics Market Report by Type, Drug Type, Distribution Channel, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
口腔乾燥症（ドライマウス）治療薬市場レポート：タイプ別、薬剤タイプ別、流通チャネル別、地域別2024-2032
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

口腔乾燥症（ドライマウス）治療薬の世界市場規模は、2023年に7億3,980万米ドルに達しました。今後、IMARC Groupは、市場が2032年までに9億8,500万米ドルに達し、2024年から2032年の間に3.13%の成長率（CAGR）を示すと予測しています。

口腔乾燥症（ドライマウス）とは、通常、唾液量の減少によって引き起こされる口腔乾燥の症状や感覚を指します。この症状は、頸部や頭部への放射能の悪影響、抗不安薬の消費量の増加、脱水、糖尿病、アルツハイマー病などによって引き起こされます。唾液腺ペンや唾液分泌促進剤、人工唾液、処方された薬、水をすする、唇を保湿するなどの家庭療法で治療することができます。これとは別に、開業医による唾液腺の早期診断や、市販の（OTC）洗浄剤など、推奨される口腔保湿製品の使用は、口腔内の潤滑を助けることができます。これらの治療は不快感を和らげ、重篤な合併症を予防し、味覚障害を治し、口臭や味覚障害を緩和します。その結果、口腔乾燥症（ドライマウス）治療薬は、唾液腺機能の低下に対処するために複数の病院や診療所で使用されています。

口腔乾燥症（ドライマウス）治療薬の市場動向：

放射線療法や化学療法の副作用により、特に老年人口の間でドライマウスが増加しており、ドライマウス緩和製品に対するニーズが高まっていることが、主に市場成長の原動力となっています。さらに、口腔乾燥を引き起こすシェーグレン症候群、アルツハイマー病、ヒト免疫不全ウイルス（HIV）の治療薬として、処方箋に基づく歯磨き粉、ビタミングミ、医薬品の利用が増加していることも成長を促す要因となっています。これに伴い、口腔乾燥症の早期診断に関する消費者の意識の高まり、医療費の大幅な増加、多様な診断技術の登場が市場成長を後押ししています。さらに、口腔乾燥症という病気、その症状、原因、治療に関して消費者を感化するために、政府によって好意的な取り組みが開始されていることも、市場の成長を後押ししています。これとは別に、様々な治療薬が容易に入手可能であり、研究開発（R&D）活動が進行中であることも、市場に明るい見通しをもたらしています。

本レポートで扱う主な質問

  • 口腔乾燥症（ドライマウス）治療薬の世界市場規模は？
  • 2024年から2032年にかけての口腔乾燥症（ドライマウス）治療薬世界市場の予想成長率は？
  • 口腔乾燥症（ドライマウス）治療薬の世界市場を牽引する主な要因は何ですか？
  • 口腔乾燥症（ドライマウス）治療薬の世界市場におけるCOVID-19の影響は？
  • 口腔乾燥症（ドライマウス）治療薬の世界市場におけるタイプ別の区分は？
  • 薬剤タイプ別の口腔乾燥症（ドライマウス）治療薬の世界市場内訳は？
  • 口腔乾燥症（ドライマウス）治療薬の世界市場における流通チャネル別の内訳は？
  • 口腔乾燥症（ドライマウス）治療薬の世界市場における主要地域は？
  • 口腔乾燥症（ドライマウス）治療薬の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の口腔乾燥症（ドライマウス）治療薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 人工唾液/唾液代替物
    • 市場動向
    • 市場予測
  • 唾液分泌促進剤
    • 市場動向
    • 市場予測

第7章 市場内訳：薬剤タイプ別

  • 店頭
    • 市場動向
    • 市場予測
  • 処方箋
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3M Company
    • Biotene（GSK plc）
    • Parnell Pharmaceuticals Inc.
    • Quest Products LLC
    • Saliwell Ltd
    • Sun Pharmaceutical Industries Limited
    • West-Ward Pharmaceutical（Hikma Pharmaceuticals plc）
図表

List of Figures

  • Figure 1: Global: Xerostomia Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Xerostomia Therapeutics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Xerostomia Therapeutics Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Xerostomia Therapeutics Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Xerostomia Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Xerostomia Therapeutics (Salivary Stimulants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Xerostomia Therapeutics (Salivary Stimulants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Xerostomia Therapeutics (OTC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Xerostomia Therapeutics (OTC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Xerostomia Therapeutics (Prescription) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Xerostomia Therapeutics (Prescription) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Xerostomia Therapeutics (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Xerostomia Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Xerostomia Therapeutics (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Xerostomia Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Xerostomia Therapeutics Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Xerostomia Therapeutics Industry: SWOT Analysis
  • Figure 72: Global: Xerostomia Therapeutics Industry: Value Chain Analysis
  • Figure 73: Global: Xerostomia Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Xerostomia Therapeutics Market: Key Industry Highlights 2023 and 2032
  • Table 2: Global: Xerostomia Therapeutics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Xerostomia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Xerostomia Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Xerostomia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Xerostomia Therapeutics Market: Competitive Structure
  • Table 7: Global: Xerostomia Therapeutics Market: Key Players
目次
Product Code: SR112024A6439

The global xerostomia (dry mouth disease) therapeutics market size reached US$ 739.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 985.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.13% during 2024-2032.

Xerostomia, or dry mouth, refers to symptoms or sensations of oral dryness that are usually caused due to a decrease in the amount of saliva. This condition is triggered by the adverse effects of radioactivity in the neck and head, increasing consumption of antianxiety drugs, dehydration, diabetes, and Alzheimer's disorder. It can be treated with the support of salivary pens or stimulants, artificial saliva, prescribed medications, and home remedies, including sipping water and moisturizing lips. Apart from this, the early diagnosis of salivary glands by practitioners and the usage of recommended mouth moisturizing products, such as over-the-counter (OTC) rinsing, can assist in lubricating the mouth. These treatments alleviate discomfort, prevent severe complications, fix taste disorders, and mitigate bad breath and taste disorders. Consequently, xerostomia therapeutics are used across several hospitals and clinics to deal with decreased salivary gland function.

Xerostomia (Dry Mouth Disease) Therapeutics Market Trends:

The increasing incidences of dry mouth, especially amongst the geriatric population, due to medicine side-effects of radiotherapy and chemotherapy and the rising need for dry mouth relief products are primarily driving the market growth. Additionally, the growing uptake of several prescription-based toothpaste, vitamin gummies, and medicines for treating Sjogren's syndrome, Alzheimer's diseases, and human immunodeficiency virus (HIV) that cause xerostomia is acting as another growth-inducing factor. In line with this, the rising consumer awareness regarding the early diagnosis of xerostomia, significant enhancements in healthcare expenditure, and the advent of diverse diagnostic technologies are propelling the market growth. Moreover, the favorable initiatives being commenced by governments to sensitize consumers regarding the xerostomia disease, its symptoms, causes, and treatments are impelling the market growth. Apart from this, the easy availability of various therapeutic drugs and ongoing research and development (R&D) activities are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global xerostomia (dry mouth disease) therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type and distribution channel.

Breakup by Type:

Artificial Saliva/Saliva Substitutes

Salivary Stimulants

Breakup by Drug Type:

OTC

Prescription

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).

Key Questions Answered in This Report

  • 1. How big is the global xerostomia (dry mouth disease) therapeutics market?
  • 2. What is the expected growth rate of the global xerostomia (dry mouth disease) therapeutics market during 2024-2032?
  • 3. What are the key factors driving the global xerostomia (dry mouth disease) therapeutics market?
  • 4. What has been the impact of COVID-19 on the global xerostomia (dry mouth disease) therapeutics market?
  • 5. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on type?
  • 6. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the drug type?
  • 7. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the distribution channel?
  • 8. What are the key regions in the global xerostomia (dry mouth disease) therapeutics market?
  • 9. Who are the key players/companies in the global xerostomia (dry mouth disease) therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Xerostomia (Dry Mouth Disease) Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Artificial Saliva/Saliva Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Salivary Stimulants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 OTC
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Prescription
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Biotene (GSK plc)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Parnell Pharmaceuticals Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Quest Products LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Saliwell Ltd
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sun Pharmaceutical Industries Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio